A bill to amend titles 10 and 38, United States Code, and other Federal laws, to improve benefits for veterans and the administration of the Department of Veterans Affairs.
Summary
S4744 is a veterans benefits improvement bill introduced in the Senate at a very early stage. No specific funding amounts, policy mechanisms, or corporate beneficiaries are identifiable from the available data, resulting in minimal near-term market impact.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.S4744 is a procedural introduction with no market-moving details available.
- 2.No funding amounts, specific programs, or corporate beneficiaries are identifiable.
- 3.Investors should monitor for committee assignment and bill text release for actionable analysis.
Market Implications
No market implications at this stage. The bill lacks specific funding, policy mechanisms, or identified beneficiaries. Investors should not adjust positions based on this introduction alone. Once committee action occurs and bill text is available, potential impacts on healthcare IT and pharmaceutical companies serving the VA may emerge.
Full Analysis
-
On June 10, 2026, Senator Jerry Moran (R-KS) introduced S4744, a bill to amend titles 10 and 38 of the U.S. Code and other federal laws to improve veterans benefits and VA administration. The bill was read the first time and placed on the Senate Legislative Calendar. It is in the earliest legislative stage with only two actions recorded, both on the introduction date.
-
The bill's title indicates it is an authorization bill, but no specific funding amount is provided in the available data. Authorization bills set policy and spending ceilings; actual appropriations require a separate bill. Without text or dollar figures, the money trail cannot be traced.
-
Veterans benefits legislation typically affects healthcare providers, pharmaceutical companies, and IT contractors serving the VA. However, without bill text, specific companies cannot be identified. Potential beneficiaries could include healthcare IT firms like $CERN or $EPIC (private), but no tickers meet the confidence threshold.
-
No real market data is provided. The legislative path is long: the bill must pass committee, receive floor votes in both chambers, and be signed into law. As a single-sponsor bill from a junior committee member (Senator Moran is not a committee chair on relevant committees), momentum is low.
-
The next steps include committee referral, hearings, markups, and potential amendments. Passage in the 119th Congress is uncertain given the early stage and lack of co-sponsors or companion legislation.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.